Falcon Edge Capital »

Liminatus Pharma shares owned by Falcon Edge Capital

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Falcon Edge Capital from 13F filings

Historical chart of Falcon Edge Capital investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Falcon Edge Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Falcon Edge Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 89k 0.12
2025-06-30 $22k 89k 0.24

More positions owned by Falcon Edge Capital

Qxo Com New (QXO)
Lenz Therapeutics (LENZ)
Mestera (MTSR)
RadNet (RDNT)
Boeing Company (BA)
Woodward Governor Company (WWD)
Alto Neuroscience Com Shs (ANRO)
Masimo Corporation (MASI)
Klarna Group SHS
Trimas Corp Com New (TRS)
Resideo Technologies (REZI)
Huntington Ingalls Inds (HII)
Ingevity (NGVT)
Energy Recovery (ERII)
Certara Ord (CERT)

View all positions for Falcon Edge Capital

Top funds holding Liminatus Pharma

Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital
Toronto-Dominion Bank

View all funds holding Liminatus Pharma